Correlia Biosystems

About:

Correlia Biosystems develops microscale tools that accelerate the rate of molecular interactions, allowing for measurements of biomolecules.

Website: http://www.correliabio.com

Twitter/X: correlia_bio

Top Investors: National Science Foundation, Creative Destruction Lab (CDL), Y Combinator, Cota Capital, Pangaea Ventures

Description:

Correlia Biosystems develops microscale tools that accelerate the rate of molecular interactions, allowing for measurements of biomolecules. Correlia Biosystems is a UC Berkeley spinoff that creates protein measurement tools that are inexpensive, quick, and customizable. Their adaptable SimpleScan technology has a wide range of applications, from point-of-care diagnostics to rapid and multiplexed proteomics research.

Total Funding Amount:

$10.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)correliabio.com

Founders:

Akwasi Apori, Kursad Araz, Samuel Tia

Number of Employees:

1-10

Last Funding Date:

2020-10-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai